Nasal spray drug study seeks healthy volunteers
NCT ID NCT06954428
First seen Feb 23, 2026 · Last updated May 09, 2026 · Updated 10 times
Summary
This study tested a new nasal spray form of the drug apomorphine (NT-301) in 49 healthy adults. The goal was to check its safety, how well it is tolerated, and how the body absorbs it compared to the standard injection. Participants received either the nasal spray or a placebo, and some later received both the spray and injection to compare results.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for TOLERABILITY OF NT-301 NASAL SPRAY are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Locations
-
CMAX
Adelaide, South Australia, Australia
-
CMAX Clinical Research Center Pty Limited
Adelaide, South Australia, 5000, Australia
Conditions
Explore the condition pages connected to this study.